Document Type
Editorial
Publication Date
1-25-2018
Digital Object Identifier (DOI)
https://doi.org/10.1056/NEJMe1714638
Related Content
Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.
Repository Citation
Murphy, Michael Paul, "Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease" (2018). Molecular and Cellular Biochemistry Faculty Publications. 136.
https://uknowledge.uky.edu/biochem_facpub/136
nejme1714638_disclosures.pdf (80 kB)
Disclosure Forms
Disclosure Forms
PlumX Metrics
- Citations
- Citation Indexes: 38
- Patent Family Citations: 1
- Policy Citations: 3
- Usage
- Downloads: 679
- Abstract Views: 5
- Captures
- Readers: 95
- Mentions
- Blog Mentions: 1
- News Mentions: 8
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Diseases Commons, Neurology Commons
Notes/Citation Information
Published in The New England Journal of Medicine, v. 378, no. 4, p. 391-392.
From The New England Journal of Medicine, M. Paul Murphy, Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease, 387, 391-392. Copyright © 2018 Massachusetts Medical Society. Reprinted with permission.